{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:05:51Z","timestamp":1787583951397,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2019R1F1A1044048"],"award-info":[{"award-number":["2019R1F1A1044048"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Amyotrophic lateral sclerosis (ALS) is a devasting neurodegenerative disorder for which no successful therapeutics are available. Valproic acid (VPA), a monocarboxylate derivative, is a known antiepileptic drug and a histone deacetylase inhibitor.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To investigate whether monocarboxylate transporter 1 (MCT1) and sodium-coupled MCT1 (SMCT1) are altered in ALS cell and mouse models, a cellular uptake study, quantitative real time polymerase chain reaction and western blot parameters were used. Similarly, whether VPA provides a neuroprotective effect in the wild-type (WT; hSOD1WT) and ALS mutant-type (MT; hSOD1G93A) NSC-34 motor neuron-like cell lines was determined through the cell viability assay.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>[<jats:sup>3<\/jats:sup>H]VPA uptake was dependent on time, pH, sodium and concentration, and the uptake rate was significantly lower in the MT cell line than the WT cell line. Interestingly, two VPA transport systems were expressed, and the VPA uptake was modulated by SMCT substrates\/inhibitors in both cell lines. Furthermore, MCT1 and SMCT1 expression was significantly lower in motor neurons of ALS (G93A) model mice than in those of WT mice. Notably, VPA ameliorated glutamate- and hydrogen peroxide-induced neurotoxicity in both the WT and MT ALS cell lines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Together, the current findings demonstrate that VPA exhibits a neuroprotective effect regardless of the dysfunction of an MCT in ALS, which could help develop useful therapeutic strategies for ALS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12929-022-00785-3","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T08:02:54Z","timestamp":1641801774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"29","author":[{"given":"Asmita","family":"Gyawali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hye","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Jae","family":"Hyeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Sook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"785_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fnins.2016.00611","volume":"10","author":"TW Tefera","year":"2017","unstructured":"Tefera TW, Borges K. Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front Neurosci. 2017;10:611.","journal-title":"Front Neurosci"},{"key":"785_CR2","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:17071.","journal-title":"Nat Rev Dis Prim"},{"key":"785_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tins.2014.05.006","volume":"37","author":"S Vucic","year":"2014","unstructured":"Vucic S, Rothstein JD, Kiernan MC. Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies. Trends Neurosci. 2014;37:433\u201342.","journal-title":"Trends Neurosci"},{"key":"785_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","volume":"48","author":"SC Barber","year":"2010","unstructured":"Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010;48:629\u201341.","journal-title":"Free Radic Biol Med"},{"key":"785_CR5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772\u20135.","journal-title":"Science"},{"key":"785_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.xphs.2020.10.030","volume":"110","author":"A Gyawali","year":"2021","unstructured":"Gyawali A, Kang YS. Transport alteration of 4-phenyl butyric acid mediated by a sodium- and proton-coupled monocarboxylic acid transporter system in ALS model cell lines (NSC-34) under inflammatory states. J Pharm Sci. 2021;110:1374\u201384.","journal-title":"J Pharm Sci"},{"key":"785_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/biomedicines9010009","volume":"9","author":"A Gyawali","year":"2021","unstructured":"Gyawali A, Kang YS. Pretreatment effect of inflammatory stimuli and characteristics of tryptophan transport on brain capillary endothelial (TR-BBB) and motor neuron like (NSC-34) cell lines. Biomedicines. 2021;9:9.","journal-title":"Biomedicines"},{"key":"785_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12035-020-02143-6","volume":"58","author":"A Gyawali","year":"2021","unstructured":"Gyawali A, Gautam S, Hyeon SJ, Ryu H, Kang YS. L-Citrulline level and transporter activity are altered in experimental models of amyotrophic lateral sclerosis. Mol Neurobiol. 2021;58:647\u201357.","journal-title":"Mol Neurobiol"},{"key":"785_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/pharmaceutics13040551","volume":"13","author":"A Gyawali","year":"2021","unstructured":"Gyawali A, Hyeon SJ, Ryu H, Kang YS. The alteration of L-carnitine transport and pretreatment effect under glutamate cytotoxicity on motor neuron-like NSC-34 lines. Pharmaceutics. 2021;13:551.","journal-title":"Pharmaceutics"},{"key":"785_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2174\/13816128113199990462","volume":"20","author":"N Vijay","year":"2014","unstructured":"Vijay N, Morris M. Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des. 2014;20:1487\u201398.","journal-title":"Curr Pharm Des"},{"key":"785_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/cpt.418","volume":"100","author":"RS Jones","year":"2016","unstructured":"Jones RS, Morris ME. Monocarboxylate transporters: therapeutic targets and prognostic factors in disease. Clin Pharmacol Ther. 2016;100:454\u201363.","journal-title":"Clin Pharmacol Ther"},{"key":"785_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbrc.2020.01.139","volume":"524","author":"T Yuri","year":"2020","unstructured":"Yuri T, Kono Y, Fujita T. Transport characteristics of 5-aminosalicylic acid into colonic epithelium: Involvement of sodium-coupled monocarboxylate transporter SMCT1-mediated transport system. Biochem Biophys Res Commun. 2020;524:561\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"785_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/cts.12551","volume":"11","author":"P Fisel","year":"2018","unstructured":"Fisel P, Schaeffeler E, Schwab M. Clinical and functional relevance of the monocarboxylate transporter family in disease pathophysiology and drug therapy. Clin Transl Sci. 2018;11:352\u201364.","journal-title":"Clin Transl Sci"},{"key":"785_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1124\/dmd.109.027169","volume":"37","author":"D Cui","year":"2009","unstructured":"Cui D, Morris ME. The drug of abuse \u03b3-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition. Drug Metab Dispos. 2009;37:1404\u201310.","journal-title":"Drug Metab Dispos"},{"key":"785_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.expneurol.2014.10.018","volume":"263","author":"BM Morrison","year":"2015","unstructured":"Morrison BM, Tsingalia A, Vidensky S, Lee Y, Jin L, Farah MH, et al. Deficiency in monocarboxylate transporter 1 (MCT1) in mice delays regeneration of peripheral nerves following sciatic nerve crush. Exp Neurol. 2015;263:325\u201338.","journal-title":"Exp Neurol"},{"key":"785_CR16","first-page":"479364","volume":"2010","author":"M Diederich","year":"2010","unstructured":"Diederich M, Chateauvieux S, Morceau F, Dicato M. Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol. 2010;2010:479364.","journal-title":"J Biomed Biotechnol"},{"key":"785_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","volume":"16","author":"W L\u00f6scher","year":"2002","unstructured":"L\u00f6scher W. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002;16:669\u201394.","journal-title":"CNS Drugs"},{"key":"785_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2217\/rme.14.86","volume":"10","author":"T Chu","year":"2015","unstructured":"Chu T, Zhou H, Lu L, Kong X, Wang T, Pan B, et al. Valproic acid-mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential. Regen Med. 2015;10:193\u2013209.","journal-title":"Regen Med"},{"key":"785_CR19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1089\/neu.2013.3146","volume":"31","author":"JY Lee","year":"2014","unstructured":"Lee JY, Maeng S, Kang SR, Choi HY, Oh TH, Ju BG, et al. Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome c release after spinal cord injury. J Neurotrauma. 2014;31:582\u201394.","journal-title":"J Neurotrauma"},{"key":"785_CR20","first-page":"309","volume":"53","author":"E Naga\u0144ska","year":"2015","unstructured":"Naga\u0144ska E, Matyja E, Taraszewska A, Rafa\u0142owska J. Protective effect of valproic acid on cultured motor neurons under glutamate excitotoxic conditions. Ultrastructural study Folia. Neuropathol. 2015;53:309\u201316.","journal-title":"Neuropathol"},{"key":"785_CR21","first-page":"648","volume":"34","author":"J Wang","year":"2013","unstructured":"Wang J, Feng H, Zhang J, Jiang H. Lithium and valproate acid protect NSC34 cells from H2O2-induced oxidative stress and upregulate expressions of SIRT3 and CARM1. Neuroendocrinol Lett. 2013;34:648\u201354.","journal-title":"Neuroendocrinol Lett"},{"key":"785_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12035-012-8371-9","volume":"47","author":"MK Jung","year":"2013","unstructured":"Jung MK, Kim KY, Lee NY, Kang YS, Hwang YJ, Kim Y, et al. Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS. Mol Neurobiol. 2013;47:699\u2013710.","journal-title":"Mol Neurobiol"},{"key":"785_CR23","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.xphs.2018.11.040","volume":"108","author":"A Gyawali","year":"2019","unstructured":"Gyawali A, Kang YS. Blood-to-retina transport of imperatorin involves the carrier-mediated transporter system at the inner blood-retinal barrier. J Pharm Sci. 2019;108:1619\u201326.","journal-title":"J Pharm Sci"},{"key":"785_CR24","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1007\/s00018-013-1415-0","volume":"70","author":"RS Pandya","year":"2013","unstructured":"Pandya RS, Zhu H, Li W, Bowser R, Friedlander RM, Wang X. Therapeutic neuroprotective agents for amyotrophic lateral sclerosis. Cell Mol Life Sci. 2013;70:4729\u201345.","journal-title":"Cell Mol Life Sci"},{"key":"785_CR25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","volume":"1762","author":"L Van Den Bosch","year":"2006","unstructured":"Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta Mol Basis Dis. 2006;1762:1068\u201382.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"785_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0014-2999(01)00912-8","volume":"417","author":"F Ushigome","year":"2001","unstructured":"Ushigome F, Takanaga H, Matsuo H, Tsukimori K, Nakano H, Ohtani H, et al. Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo). Eur J Pharmacol. 2001;417:169\u201376.","journal-title":"Eur J Pharmacol"},{"key":"785_CR27","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1242\/jcs.084285","volume":"124","author":"N Terbach","year":"2011","unstructured":"Terbach N, Shah R, Kelemen R, Klein PS, Gordienko D, Brown NA, et al. Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium. J Cell Sci. 2011;124:2267\u201376.","journal-title":"J Cell Sci"},{"key":"785_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejpb.2008.05.022","volume":"70","author":"W Fischer","year":"2008","unstructured":"Fischer W, Praetor K, Metzner L, Neubert RHH, Brandsch M. Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: mechanism and substrate specificity. Eur J Pharm Biopharm. 2008;70:486\u201392.","journal-title":"Eur J Pharm Biopharm"},{"key":"785_CR29","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/cphy.c130008","volume":"3","author":"AP Halestrap","year":"2013","unstructured":"Halestrap AP. Monocarboxylic acid transport. Compr Physiol. 2013;3:1611\u201343.","journal-title":"Compr Physiol"},{"key":"785_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","volume":"10","author":"V Ganapathy","year":"2008","unstructured":"Ganapathy V, Thangaraju M, Gopal E, Martin PM, Itagaki S, Miyauchi S, et al. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J. 2008;10:193\u20139.","journal-title":"AAPS J"},{"key":"785_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.dmpk.2018.03.004","volume":"33","author":"Y Ishiguro","year":"2018","unstructured":"Ishiguro Y, Furugen A, Narumi K, Nishimura A, Hirano T, Kobayashi M, et al. Valproic acid transport in the choriocarcinoma placenta cell line JEG-3 proceeds independently of the proton-dependent transporters MCT1 and MCT4. Drug Metab Pharmacokinet. 2018;33:270\u20134.","journal-title":"Drug Metab Pharmacokinet"},{"key":"785_CR32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/01616412.2016.1173324","volume":"38","author":"Y Guo","year":"2016","unstructured":"Guo Y, Jiang L. Organic anion transporting polypeptide 2 transports valproic acid in rat brain microvascular endothelial cells. Neurol Res. 2016;38:634\u20139.","journal-title":"Neurol Res"},{"key":"785_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1124\/dmd.106.013912","volume":"35","author":"N Mizuno","year":"2007","unstructured":"Mizuno N, Takahashi T, Iwase Y, Kusuhara H, Niwa T, Sugiyama Y. Human organic anion transporters 1 (hOAT1\/SLC22A6) and 3 (hOAT3\/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab Dispos. 2007;35:1429\u201334.","journal-title":"Drug Metab Dispos"},{"key":"785_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443\u20138.","journal-title":"Nature"},{"key":"785_CR35","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.bbamcr.2016.03.013","volume":"1863","author":"J P\u00e9rez-Escuredo","year":"2016","unstructured":"P\u00e9rez-Escuredo J, Van H\u00e9e VF, Sboarina M, Falces J, Payen VL, Pellerin L, et al. Monocarboxylate transporters in the brain and in cancer. Biochim Biophys Acta Mol Cell Res. 2016;1863:2481\u201397.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"785_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.9758\/cpn.2020.18.2.174","volume":"18","author":"A Ayka\u00e7","year":"2020","unstructured":"Ayka\u00e7 A, \u015eehirli A\u00d6. The role of the SLC transporters protein in the neurodegenerative disorders. Clin Psychopharmacol Neurosci. 2020;18:174\u201387.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"785_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1874467210902010095","volume":"2","author":"B Monti","year":"2009","unstructured":"Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol. 2009;2:95\u2013109.","journal-title":"Curr Mol Pharmacol"},{"key":"785_CR38","first-page":"1","volume":"17","author":"HZ Jiang","year":"2016","unstructured":"Jiang HZ, Wang SY, Yin X, Jiang HQ, Wang XD, Wang J, et al. Downregulation of Homer1b\/c in SOD1 G93A models of ALS: a novel mechanism of neuroprotective effect of lithium and valproic acid. Int J Mol Sci. 2016;17:1\u201312.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-022-00785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-022-00785-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-022-00785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T08:03:37Z","timestamp":1641801817000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-022-00785-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1186\/s12929-022-00785-3","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"27 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Korea Institute of Science and Technology (IACUC approval no. KIST-2021-05-062).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}